Clinical Relevance of Alternative Endpoints in Colorectal Cancer First-Line Therapy With Bevacizumab: A Retrospective Study.

Anthony Turpin,Sophie Paget-Bailly,Anne Ploquin,Antoine Hollebecque,Charlotte Peugniez,Farid El-Hajbi,Franck Bonnetain,Mohamed Hebbar

Clinical Colorectal Cancer（2018）

引用 2|浏览16

暂无评分

摘要

DDC and TFS correlated with OS and are relevant as intermediate criteria in the setting of patients with mCRC treated with a first-line bevacizumab-based regimen.

查看译文

关键词

Alternative endpoints,Duration of disease control,Maintenance,Metastatic colorectal cancer,Time to failure of strategy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要